6-Methyl-9-(2-C-methyl-β-D-ribofuranosyl)purine is a purine nucleoside analog with broad antitumor activity, particularly targeting indolent lymphoid malignancies. Its anticancer mechanism involves inhibition of DNA synthesis and induction of apoptosis.